Alzheimer’s disease (AD) is a neurodegenerative disorder associated with memory impairment and cognitive deficit. Most of the drugs currently available for the treatment of AD are acetylcholinesterase (AChE) inhibitors. In a preliminary study, significant AChE inhibition was observed for the ethanolic extract of Grindelia ventanensis (IC50 = 0.79 mg/mL). This result prompted us to isolate the active constituent, a normal labdane diterpenoid identified as 17-hydroxycativic acid (1), through a bioassay guided fractionation. Taking into account that 1 showed moderate inhibition of AChE (IC50 = 21.1 lM), selectivity over butyrylcholinesterase (BChE) (IC50 = 171.1 lM) and that it was easily obtained from the plant extract in a very good yield (0...
Abstract: As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheim...
68 p.-17 fig.-1 tab. Chierrito, Talita P. C. et al.The lack of an effective treatment for Alzheimer'...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia ...
The investigation of natural products in medicinal chemistry is essential today. In this context, ac...
Alzheimer’s disease (AD) is a brain disease characterized by gradual memory loss and cognitive impai...
Currently approved Alzheimer’s disease medications mainly comprise acetylcholinesterase inhibitors. ...
Alzheimer’s disease (AD) lies in the category of those diseases which are still posing challenges to...
To date, Alzheimers disease is the most alarming neurodegenerative disorder worldwide. This illness ...
Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and c...
Alzheimer’s disease (AD) is a progressive and neurodegenerative pathology that can affect people ove...
Acetylcholinesterase acts as a catalyst in the hydrolysis of the neurotransmitter acetylcholine. How...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive ...
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease, distinctively charac...
23 p.-6 fig.-1 tab.A novel series of aromatic esters (1a-1m) related to the Amaryllidaceae alkaloid ...
A series of novel 4-isochromanone compounds bearing N-benzyl pyridinium moiety were designed and syn...
Abstract: As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheim...
68 p.-17 fig.-1 tab. Chierrito, Talita P. C. et al.The lack of an effective treatment for Alzheimer'...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia ...
The investigation of natural products in medicinal chemistry is essential today. In this context, ac...
Alzheimer’s disease (AD) is a brain disease characterized by gradual memory loss and cognitive impai...
Currently approved Alzheimer’s disease medications mainly comprise acetylcholinesterase inhibitors. ...
Alzheimer’s disease (AD) lies in the category of those diseases which are still posing challenges to...
To date, Alzheimers disease is the most alarming neurodegenerative disorder worldwide. This illness ...
Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and c...
Alzheimer’s disease (AD) is a progressive and neurodegenerative pathology that can affect people ove...
Acetylcholinesterase acts as a catalyst in the hydrolysis of the neurotransmitter acetylcholine. How...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive ...
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease, distinctively charac...
23 p.-6 fig.-1 tab.A novel series of aromatic esters (1a-1m) related to the Amaryllidaceae alkaloid ...
A series of novel 4-isochromanone compounds bearing N-benzyl pyridinium moiety were designed and syn...
Abstract: As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheim...
68 p.-17 fig.-1 tab. Chierrito, Talita P. C. et al.The lack of an effective treatment for Alzheimer'...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia ...